Singapore markets open in 4 hours 46 minutes

Veru Inc. (VERU)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
11.52-0.20 (-1.71%)
At close: 04:00PM EDT
11.52 0.00 (0.00%)
After hours: 07:55PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close11.72
Open11.51
Bid11.51 x 1300
Ask11.57 x 4000
Day's range11.08 - 11.88
52-week range4.34 - 24.55
Volume4,220,673
Avg. volume9,000,668
Market cap923.29M
Beta (5Y monthly)-0.44
PE ratio (TTM)N/A
EPS (TTM)-0.35
Earnings date30 Nov 2022 - 05 Dec 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend date28 Apr 2014
1y target est35.20
  • Motley Fool

    Got $1,500? Buy These 2 Surging Growth Stocks

    In today's bearish market, consistent growth is hard to come by, but it still exists. With its shares up over 142% so far this year, it's a safe bet to call Veru (NASDAQ: VERU) a growth stock that's on a tear. The answer is that Veru is developing a treatment for severe COVID-19 called sabizabulin, and it's currently waiting on the final stamp of approval from regulators at the Food and Drug Administration (FDA).

  • Motley Fool

    2 Monster Growth Stocks That Are Slaying the Bear Market

    Bear markets are often harrowing times to be invested in growth stocks, and this one's no exception. Between rising interest rates, inflation, and global disruption from the coronavirus, the shares of most growth-oriented companies have been hammered. With ShockWave Medical's (NASDAQ: SWAV) shares gaining 65.4% this year, it's safe to say that the bear market isn't causing it any problems.

  • Motley Fool

    Why Veru Stock Is Plunging Today

    Veru (NASDAQ: VERU), a high-flying cancer and COVID-19 stock, is in full-on retreat mode today. The good news is that Veru didn't release any material news today, so its value proposition hasn't suddenly changed. The bad news is that investors appear to be profit-taking across the varied healthcare landscape today in response to the Federal Reserve's plans to continue raising interest rates in 2023.